** Shares of Australia's Control Bionics rise as much as 3.5% to A$0.090; on track for second straight day of gains, if trend holds
** Medical device maker signs exclusive distribution agreement with UK-based Smart Box Ltd
** Adds agreement to expand sale of co's NeuroNode device into the UK and Ireland
** NeuroNode used for individuals with conditions such as Motor Neurone Disease, cerebral palsy, and other neurological disorders that impair communication and motor function - CBL
** Stock up 95.7% YTD, as of 0220 GMT
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.